Sonic Healthcare Limited operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sonic Healthcare Limited with three other
pharmaceutical manufacturers in Australasia:
Capitol Health Ltd
(2021
sales of 178.00 million Australian Dollars [US$128.98 million]
of which 100%
was Diagnostic Imaging),
Australian Clinical Labs Ltd
(646.70 million Australian Dollars [US$468.63 million]
of which 100%
was Pathology), and
Integral Diagnostics Ltd
(350.70 million Australian Dollars [US$254.13 million]
of which 100%
was Diagnostic imaging facilities).
Sales Analysis.
Sonic Healthcare Limited reported sales of A$8.75 billion (US$6.34 billion)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 28.1%
versus 2020, when the company's sales were A$6.83 billion.
Sales at Sonic Healthcare Limited have increased during each of the previous five years
(and since 2016, sales have increased a total of 74%).
Sales of Laboratory saw an increase
of
42.7% in 2021, from
A$5.67 billion to A$8.10 billion.
Not all segments of Sonic Healthcare Limited experienced an increase in sales in 2021:
sales of Other fell 6.9% to A$410.52 million.